Compositions and Methods for Treating Alopecia and Related Disorders
The present disclosure is in the field of pharmaceutical compositions suitable for the treatment of diseases in mammals. The disclosure provides novel compositions comprising non-pathogenic fecal microbes for treating alopecia and related diseases. The disclosure also provides methods for treating a subject with the compositions disclosed herein.
1 . A method for treating alopecia in a subject in need thereof, said method comprising administering to said subject a pharmaceutically active dose of a therapeutic composition comprising live non-pathogenic fecal bacteria.
2 . The method of claim 1 , wherein said alopecia affects the scalp of said subject.
3 . The method of claim 1 , wherein said alopecia presents as one or more patches of hair loss.
4 . The method of claim 3 , wherein said one or more patches of hair loss comprise multiple patches.
5 . The method of claim 3 , wherein said treating comprises reducing a size of said one or more patches of hair loss.
6 . The method of claim 4 , wherein said treating comprises reducing a number of said multiple patches.
7 . The method of claim 1 , wherein said alopecia is alopecia areata.
8 . The method of claim 2 , wherein said alopecia results in hair loss on all or substantially all of said scalp of said subject.
9 . The method of claim 8 , wherein said alopecia is alopecia totalis.
10 . The method of claim 1 , wherein said alopecia results in hair loss on all or substantially all of the body of said subject.
11 . The method of claim 10 , wherein said alopecia is alopecia universalis.
12 . The method of claim 1 , wherein said treating comprises inducing growth of hair on a body surface of said subject.
13 . The method of claim 1 , wherein said treating comprises increasing a number of hairs on a body surface of said subject.
14 . The method of claim 1 , wherein said treating comprises increasing a width of one or more hairs on a body surface of said subject.
15 . The method of claim 1 , wherein said live non-pathogenic fecal bacteria comprises a preparation of uncultured fecal bacteria.
16 . The method of claim 1 , wherein said composition comprises an isolated or purified population of said live non-pathogenic fecal bacteria.
17 . The method of claim 1 , wherein said administration is on a daily or weekly basis.
18 . The method of claim 1 , wherein said administration lasts at least 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 weeks.
19 . The method of claim 1 , wherein said administering comprises oral administration.
20 . The method of claim 1 , wherein said method further comprises administering one or more medications selected from the group consisting of an immunomodulator, a corticosteroid, minoxidil, diphenylcyclopropenone (DPCP), and combinations thereof.